Synthesis and characterization of cis-[(PPh3)2Pt{9-MeAd(-H),NN}]X (X = NO3, PF6): The first example of a platinum(II) complex containing the N,N-chelated 9-methyladenine anion

Reaction between the binuclear hydroxo complex cis-[(PPh₃)₂Pt(μ-OH)]₂X₂ (X⁻ = NO₃, 1a; , 1b) and the model DNA base 9-methyladenine (9-MeAd) leads to the formation of the mononuclear species cis-[(PPh₃)₂Pt{9-MeAd(-H),N⁶N⁷}]X (X⁻ = NO₃, 2a; PF₆, 2b), in which the nucleobase chelates the Pt(II) ion with the N6 and N7 atoms. The coordination mode of the nucleobase has been determinated through a multinuclear (¹H, ³¹P, ¹³C, ¹⁵N and ¹⁹⁵Pt) NMR analysis and the nuclearity of the complex has been obtained by E.S.I. mass spectrometry. 2 represents the first example of an isolated platinum complex in which the NH₂-deprotonated adenine exhibits this binding mode.     

Complexes of hybrid ligands. Synthesis of mixed-ligand,phosphino-alkoxide complexes of Pd2+: the crystal and molecular structure of the complex Ph2 PCH2C(CF3 )2OPdCl(PPh2Me)

The hybrid, bidentate, diarylphosphino-alkoxide ligand PPh₂CH₂C(CF₃)₂O⁻, L¹, gives the Pd²⁺ bis- complex Pd(L¹)₂, from which the chloride-bridged dinuclear complex [(L¹)Pd(μ-Cl)₂Pd(L¹)] is made by reaction with PdCl₂(PhCN)₂. Cleavage of the dinuclear complex with monodentate ligands L² then gives Pd(L¹)Cl(L²) (L² =PPh₃, PPh₂Me, PPhMe₂, PMe₃, SMe₂, or pyridine); NMR data show that PR₃ is cis to the phosphine site in L¹ in these complexes, but SMe₂ or pyridine are probably trans.A complete crystal and molecular structural determination has been made for cis-Pd(L¹)Cl(PPh₂Me). Crystals are monoclinic, space group P2₁/c, a = 10.821(1), b = 14.600(1), c = 18.674(2) Å, β = 101.25(1)°, V = 2893 ų, Z = 4. Least-squares refinement on F of 361 variables using 3977 observations converged at a conventional agreement factor R = 0.025. The complex is square-planar, with the two phosphines cis; the 5-membered chelate ring is in a dissymmetric envelope conformation. The PdP bonds differ in length, with that to the unidentate phosphine, 2.259(1) Å, being significantly longer than that to the phosphine on the chelating ligand, 2.231(1) Å.     

Reactions of the fac-[Re(CO)3] and [ReO] moieties with substituted benzothiazoles

The reaction of 2-(2-aminophenyl)benzothiazole (Habt) with [Re(CO)₅Br] led to the isolation of the rhenium(I) complex fac-[Re(Habt)(CO)₃Br] (1). With trans-[ReOCl₃(PPh₃)₂], the ligand Habt decomposed to form the oxofree rhenium(V) complex [Re(itp)₂Cl(PPh₃)] (2) (itp = 2-amidophenylthiolate). From the reaction of trans-[ReOBr₃(PPh₃)₂] with 2-(2-hydroxyphenyl)benzothiazole (Hhpd) the complex [Re^VOBr₂(hpd)(PPh₃)] (3) was obtained. Complexes 1-3 are stable and lipophilic. ¹H NMR and infrared assignments, as well as the X-ray crystal structures, of the complexes are reported.     

Coordination chemistry of Re complexes with 2(2′-pyridyl)benzimidazole

Two new Re(III) and Re(IV) complexes with 2(2′-pyridyl)benzimidazole (pbimz) were prepared and their crystal and molecular structures established by single-crystal X-ray diffraction. Reaction of [ReOCl₂(OEt)(PPh₃)₂] with the ligand gave red cis(Cl),trans(P)-[ReCl₂(PPh₃)₂(pbimz)]Cl (1), while red [ReCl₄(pbimz)] · OPPh₃ (2) was obtained from [ReCl₃(PhC(O)C(O)Ph)(PPh₃)] and pbimz in the presence of perchlorate. The compounds were characterized by elemental analysis, FAB-MS, UV-Vis, IR, NMR spectroscopy and magnetic susceptibility measurements.     

Synthesis, characterization and cytotoxic properties of platinum(II) complexes containing the nucleosides adenosine and cytidine

Cytidine (cyt) and adenosine (ado) react with cis-[L₂Pt(μ-OH)]₂(NO₃)₂ (L = PMe₃, PPh₃) in various solvents to give the nucleoside complexes cis-[L₂Pt{cyt(− H),N³N⁴}]₃(NO₃)₃ (L = PMe₃, 1),cis-[L₂Pt{cyt(− H),N⁴}(cyt,N³)]NO₃ (L = PPh₃, 2), cis-[L₂Pt{ado(− H),N¹N⁶}]₂(NO₃)₂ (L = PMe₃, 3) and cis-[L₂Pt{ado(− H),N⁶N⁷}]NO₃ (L = PPh₃, 4). When the condensation reaction is carried out in solution of nitriles (RCN, R = Me, Ph) the amidine derivatives cis-[(PPh₃)₂PtNH=C(R){cyt(− 2H)}]NO₃ (R = Me, 5a; R = Ph, 5b) and cis-[(PPh₃)₂PtNH=C(R){ado(− 2H)}]NO₃ (R = Me, 6a: R = Ph, 6b) are quantitatively formed. The coordination mode of these nucleosides, characterized in solution by multinuclear NMR spectroscopy and mass spectrometry, is similar to that previously observed for the nucleobases 1-methylcytosine (1-MeCy) and 9-methyladenine (9-MeAd). The cytotoxic properties of the new complexes, and those of the nucleobase analogs, cis-[(PPh₃)₂PtNH=C(R){1-MeCy(− 2H)}]NO₃ (R = Me, 7a: R = Ph, 7b), cis-[(PPh₃)₂PtNH=C(R){9-MeAd(− 2H)}]NO₃ (R = Me, 8a: R = Ph, 8b) have been investigated in a wide panel of human cancer cells. Interestingly, whereas the Pt(II) nucleoside complexes (1-4) did not show appreciable cytotoxicity, the corresponding amidine derivatives (7a, 7b, 8a, 8b, 5b, and 6b) exhibited a significant in vitro antitumor activity.     

Synthesis, characterization, spectroscopic and electrochemical properties of trans,trans,trans-bis(triphenyl phosphine) bis(aroyl hydrazonato)ruthenium(II) complexes

Four ruthenium (II) complexes of general formula Ru(PPh₃)₂(L)₂ have been synthesized and characterized. The spectroscopic and cyclic voltammetric studies of these complexes are also reported. X-ray crystal structure determination of two of the complexes reveal that Ru(II) occupies trans,trans,trans-(t,t,t) N₂O₂P₂ centrosymmetric octahedral environments, with the ligand pair occupying the equatorial plane. ³¹P NMR confirms the presence of two trans-PPh₃ groups in all the complexes. The transformation of the complexes in dichloromethane solution is studied by spectrophotometry and ³¹P NMR spectroscopy.     

Bis(acetylacetonato)ruthenium(II) complexes containing bulky tertiary phosphines. Formation and redox behaviour of Ru(acac)2 (PR3) (R = Pr, Cy) complexes with ethene, carbon monoxide, and bridging dinitrogen

Reaction of cis-[Ru(acac)₂(η²-C₈H₁₄)₂] (1) (acac = acetylacetonato) with two equivalents of PⁱPr₃ in THF at −25 °C gives trans-[Ru(acac)₂(PⁱPr₃)₂], trans-3, which rapidly isomerizes to cis-3 at room temperature. The poorly soluble complex [Ru(acac)₂(PCy₃)₂] (4), which is isolated similarly from cis-[Ru(acac)₂(η²-C₂H₄)₂] (2) and PCy₃, appears to exist in the cis-configuration in solution according to NMR data, although an X-ray diffraction study of a single crystal shows the presence of trans-4. In benzene or toluene 2 reacts with PⁱPr₃ or PCy₃ to give exclusively cis-[Ru(acac)₂(η²-C₂H₄)(L)] [L = PⁱPr₃ (5), PCy₃ (6)], whereas in THF species believed to be either square pyramidal [Ru(acac)₂L], with apical L, or the corresponding THF adducts, can be detected by ³¹P NMR spectroscopy. Complexes 3-6 react with CO (1 bar) giving trans-[Ru(acac)₂(CO)(L)] [L = PⁱPr₃ (trans-8), PCy₃ (trans-9)], which are converted irreversibly into the cis-isomers in refluxing benzene. Complex 5 scavenges traces of dinitrogen from industrial grade dihydrogen giving a bridging dinitrogen complex, cis-[{Ru(acac)₂(PⁱPr₃)} ₂(μ-N₂)] (10). The structures of cis-3, trans-4, 5, 6 and 10 · C₆H₁₄ have been determined by single-crystal X-ray diffraction. Complexes trans- and cis-3, 5, 6, cis-8, and trans- and cis-9 each show fully reversible one-electron oxidation by cyclic voltammetry in CH₂Cl₂ at −50 °C with E_1/2(Ru^3+/2+) values spanning −0.14 to +0.92 V (versus Ag/AgCl), whereas for the vinylidene complexes [Ru(acac)₂ (CCHR)(PⁱPr₃)] [R = SiMe₃ (11), Ph (12)] the process is irreversible at potentials of +0.75 and +0.62 V, respectively. The trend in potentials reflects the order of expected π-acceptor ability of the ligands: PⁱPr₃, PCy₃ <C ₂H₄ < CCHR < CO. The UV-Vis spectrum of the thermally unstable, electrogenerated Ru^III-ethene cation 6⁺ has been observed at −50 °C. Cyclic voltammetry of the μ-dinitrogen complex 10 shows two, fully reversible processes in CH₂Cl₂ at −50 °C at +0.30 and +0.90 V (versus Ag/AgCl) corresponding to the formation of 10⁺ (Ru^II,III) and 10²⁺ (Ru^III,III). The former, generated electrochemically at −50 °C, shows a band in the near IR at ca. 8900 cm⁻¹ (w_1/2 ca. 3700 cm⁻¹) consistent with the presence of a valence delocalized system. The comproportionation constant for the equilibrium 10 + 10²⁺ ? 2 10⁺ at 223 K is estimated as 10^13.6.     

Structure and reactivity of [Ru(2,3-Medpp)2Cl2]

The structure and reactivity of the complex [Ru(2,3-Medpp)₂Cl₂](PF₆)₂ (2,3-Medpp⁺=2-[2-(1-methylpyridiniumyl)]-3-(2-pyridyl)pyrazine) was investigated by X-ray diffraction (XRD), ¹H NMR, redox, and UV-Vis absorption measurements. X-ray analysis shows that crystals obtained from an acetonitrile-toluene solution contain the trans-Cl₂, trans-pyrazine isomeric form, while ¹H NMR and redox measurements on the main product of the synthetic workup indicate the presence of the trans-Cl₂, cis-pyrazine isomer. In the dark at 70 °C, the complex [Ru(2,3-Medpp)₂Cl₂]²⁺ reacts slowly in acetonitrile isomerizing to the cis-[Ru(2,3-Medpp)₂(CH₃CN)Cl]³⁺ species. Under ambient light in the presence of excess AgNO₃ the cis-[Ru(2,3-Medpp)₂(CH₃CN)₂]⁴⁺ species is obtained.     

Low-spin, mononuclear, Fe(III) complexes with P,N donor hemilabile ligands: A combined experimental and theoretical study

Two new mononuclear Fe(III) complexes, [FeCl₃{PPh₂(p-C₆H₄NMe₂)-P}₃](1) (PPh₂(p-C₆H₄NMe₂): 4-(dimethylamino)phenyldiphenylphosphine) and [FeCl₃(PPh₂py-P)(PPh₂py-P,N)] (2) (PPh₂py: diphenyl(2-pyridyl)phosphine) were synthesized by reacting anhydrous FeCl₃ with respective ligand in acetonitrile solution under refluxing condition. Both the complexes were characterized by elemental analysis, FAB-Mass, FTIR, UV-Vis, ESR, Cyclic Voltammetry and magnetic measurement. The FAB mass spectra of complexes 1 and 2 show molecular ion peak at m/z 1078 [M]⁺ and m/z 687 [M−1]⁺, respectively, indicating mononuclear nature of the complexes. UV-Vis spectra of the complexes were consistent with low-spin, octahedral geometry. The variable temperature magnetic susceptibility measurement (73-323 K) of these complexes is also consistent with the paramagnetic nature of the complexes with a ground state spin S = ½. The Fe(III) centers of these two complexes remain low-spin, both at room temperature and liquid nitrogen temperature, was also indicated by the ESR analysis. Cyclic Voltammetry of both the complexes show an irreversible oxidation wave attributed to Fe³⁺ → Fe⁴⁺ + e⁻ along with the peak for ligand oxidation. Theoretical calculations (B3LYP) of the complexes show that for complex 1, a trans geometry of the two phosphorous atoms and for complex 2, a mer,cis structures are the most favored geometrical isomer. TDDFT calculations were performed to interpret the observed bands in the UV-Visible spectra.     

Synthesis and reactivity of gold(III) complexes containing cycloaurated iminophosphorane ligands

Transmetallation reactions of ortho-mercurated iminophosphoranes (2-ClHgC₆H₄)Ph₂PNR with [AuCl₄]⁻ gives new cycloaurated iminophosphorane complexes of gold(III) (2-Cl₂AuC₆H₄)Ph₂PNR [R = (R,S)- or (S)-CHMePh, p-C₆H₄F, ^tBu], characterised by NMR and IR spectroscopies, ESI mass spectrometry and an X-ray structure determination on the chiral derivative R = (S)-CHMePh. The chloride ligands of these complexes can be readily replaced by the chelating ligands thiosalicylate and catecholate; the resulting derivatives show markedly higher anti-tumour activity versus P388 murine leukaemia cells compared to the parent chloride complexes. Reaction of (2-Cl₂AuC₆H₄)Ph₂PNPh with PPh₃ results in displacement of a chloride ligand giving the cationic complex [(2-Cl(PPh₃)AuC₆H₄)Ph₂PNPh]⁺, indicating that the PN donor is strongly bonded to the gold centre.     

Syntheses and spectroscopic and structural characterization of silver(I) complexes containing tris(isobutyl)phosphine and poly(azol-1-yl)borates

Silver(I) derivatives [Ag(L)(PⁱBu₃)] (L = H₂B(tz)₂ (dihydrobis(1H-1,2,4-triazol-1-yl)borate), HB(tz)₃ (hydrotris(1H-1,2,4-triazol-1-yl)borate), Tp (hydrotris(1H-pyrazol-1-yl)borate), Tp∗ (hydrotris(3,5-dimethyl-1H-pyrazol-1-yl)borate), Tp^Me (hydrotris(3-methyl-1H-pyrazol-1-yl)borate), Tp^CF3 (hydrotris(3-trifluoromethyl-1H-pyrazol-1-yl)borate), Tp^4Br (hydrotris(4-bromo-1H-pyrazol-1-yl)borate), HB(btz)₃ (hydrotris(1H-1,2,4-benzotriazol-1-yl)borate), Tm (hydrotris(3-methy-1-imidazolyl-2-thione)borate), pzTp (tetrakis(1H-pyrazol-1-yl)borate), pz⁰Tp^Me (tetrakis(3-methyl-1H-pyrazol-1-yl)borate) have been synthesized from the reaction of [Ag(NO₃)(PⁱBu₃)₂] with ML (M = Na or K) and characterized both in solution (¹H- and ³¹P{¹H} NMR, ESI MS spectroscopy, conductivity) and in the solid state (IR, single crystal X-ray structure analysis). These complexes are air-stable and light-sensitive and non-electrolytes in CH₂Cl₂ and acetone in which they slowly decompose, even with the strict exclusion of oxygen and light, yielding metallic silver and/or azolate (Az) species of formula [Ag(Az)(PⁱBu₃)_x] upon breaking of the bridging B-N_(azole) bond. The solid state structures of [Ag(Tp)(PⁱBu₃)], [Ag(Tp^Me)(PⁱBu₃)], [Ag(Tp^CF3)(PⁱBu₃)], [Ag{HB(btz)₃}(PⁱBu₃)], and [Ag(Tm)(PⁱBu₃)] show that the silver atom adopts a distorted tetrahedral coordination geometry. [Ag(L)(PPh₃)] can be easily obtained from the reaction of [Ag(L)(PⁱBu₃)] with excess PPh₃, whereas from the reverse reaction of [Ag(L)(PPh₃)] with PⁱBu₃a mixture of [Ag(L)(PⁱBu₃)] and [Ag(L)]₂ and [Ag(L)(PPh₃)] was recovered. ³¹P{¹H} NMR variable temperature NMR studies showed that in the pz⁰Tp^x derivatives the scorpionate ligand acts as a bidentate donor, whereas tridentate coordination is found for all tris(azolyl)borate derivatives, both in solution and in the solid state. ESI MS data suggest the existence in solution of species such as [Ag(PⁱBu₃)₂]⁺ upon dissociation of the L ligand, and also the formation of dimeric species of the form [Ag₂(L)(PⁱBu₃)₂]⁺.     

Synthesis and characterization of Pd(II) and Pt(II) complexes with triazolopyrimidine derivatives: The crystal structure of [Pd2L2Cl4] where L = 5,7-dimethyl-1,2,4-triazolo[1,5-a]pyrimidine

The Pd(II) and Pt(II) complexes with triazolopyrimidine C-nucleosides L¹ (5,7-dimethyl-3-(2′,3′,5′-tri-O-benzoyl-β-d-ribofuranosyl-s-triazolo)[4,3-a]pyrimidine), L² (5,7-dimethyl-3-β-d-ribofuranosyl-s-triazolo[4,3-a]pyrimidine) and L³ (5,7-dimethyl[1,5-a]-s-triazolopyrimidine), [Pd(en)(L¹)](NO₃)₂, [Pd(bpy)(L¹)](NO₃)₂, cis-Pd(L³)₂Cl₂, [Pd₂(L³)₂Cl₄] · H₂O, cis-Pd(L²)₂Cl₂ and [Pt₃(L¹)₂Cl₆] were synthesized and characterized by elemental analysis and NMR spectroscopy. The structure of the [Pd₂(L³)₂Cl₄] · H₂O complex was established by X-ray crystallography. The two L³ ligands are found in a head to tail orientation, with a Pd?Pd distance of 3.1254(17) Å. L¹ coordinates to Pd(II) through N8 and N1 forming polymeric structures. L² coordinates to Pd(II) through N8 in acidic solutions (0.1 M HCl) forming complexes of cis-geometry. The Pd(II) coordination to L² does not affect the sugar conformation probably due to the high stability of the C-C glycoside bond.     

Structure and solution behaviour of cyclooctadiene complexes of platinum(II)

The substitution behaviour of [PtCl(R)(COD)] (R⁻ = Me and Fc) complexes, by the stepwise addition of phosphine ligands, L (L = PPh₃, PEt₃ and P(NMe₂)₃), were investigated in situ by ¹H and ³¹P NMR spectroscopy. Addition of less than two equivalents of the phosphine ligand results in the formation of dimeric molecules with the general formula trans-[Pt(R)(μ-Cl)(L)]₂ for the sterically demanding systems where R⁻ = Me/L = P(NMe₂)₃ and R⁻ = Fc/L = PEt₃, PPh₃ and P(NMe₂)₃ while larger quantities resulted in cis- and trans mixtures of mononuclear complexes being formed. In the case of the relatively small steric demanding, strongly coordinating, PEt₃ ligand the trans-[PtCl(R)(PEt₃)₂] mononuclear complexes were exclusively observed in both cases. The crystal structures of the two substrates, [PtCl(R)(COD)] (R⁻ = Me or Fc), as well as the cis-[PtCl(Fc)(PPh₃)₂] substitution product are reported.     

Ligand substitution reactions of the [ReX6] (X = Cl, Br) anions. Synthesis and crystal structure of novel oxalato complexes of rhenium(IV)

The reaction of K₂[ReX₆] (X = Cl, Br) with oxalic acid and triethylamine in dimethylformamide solution yields the substituted complexes [ReX₄(ox)]²⁻ and cis-[ReX₂(ox)₂]²⁻, which can be obtained separately depending on the amount of added amine. The crystal structures of (PPh₄)₂[ReBr₄(ox)], cis-(PPh₄)₂[ReBr₂(ox)₂] and cis-(AsPh₄)₂[ReCl₂(ox)₂] have been determined by single-crystal X-ray diffraction. The anionic complexes are octahedral with only slight distortions. The direct isolation of the pure complexes as well as the formation of only the cis isomers - without the presence of trans isomers and/or [Re(ox)₃]²⁻ - is probably due to the kinetic inertness of Re(IV)-X bonds, which increases with the number of oxalato ligands bound to the metal ion.     

Stereochemical structure determination of p-cymene Ru(II) complexes containing the PPh2Py ligand with 2-D NOESY and HMQC NMR experiments

Complexes [Ru(p-cymene)Cl₂(PPh₂Py)] (1) and [Ru(p-cymene)Cl(PPh₂Py)]BF₄ (2) were studied by means of ¹H, ¹³C{¹H} 2-D NOESY and HMQC NMR spectral methods. NMR data agree with C₁ and C_s symmetries for complexes 1 and 2, respectively. NOESY cross-peaks allowed the assignment of signals to CH arene protons and in the case of complex 2 the determination of the molecular stereochemistry. These results are in agreement with the X-ray molecular structures of both complexes.     

trans- and cis-Ru(II) aminophosphine complexes: Syntheses, X-ray structures and catalytic activity in transfer hydrogenation of acetophenone derivatives

The ability of transition metal catalysts to add or remove hydrogen from organic substrates by transfer hydrogenation process is a valuable synthetic tool. For this aim, a novel Ru(II) complex with the P-N ligand [(Ph₂P)₂NCH₂-C₄H₃S] derived from thiophene-2-methylamine was synthesized starting with the complex [Ru(η⁶-p-cymene)(μ-Cl)Cl]₂ and isolated in two isomeric forms: trans- and cis-[Ru((PPh₂)₂NCH₂-C₄H₃S)₂Cl₂], 2 and 3, respectively. The structures of both isomers were also determined by single crystal X-ray diffraction. The cis-isomer 3 can be isolated from the solution of major trans-isomer 2 as yellow crystals. However, upon dissolution 3 is rapidly converted to the trans-isomer 2. The new ruthenium(II) complex provides high catalytic activity in the transfer hydrogenation of acetophenone derivatives to 1-phenylethanol derivatives in the presence of 2-propanol as the hydrogen source. This transfer hydrogenation is characterized by low reversibility under the experimental conditions.     

Studies on the reactions of ruthenium(II) substrates with tridentate (N,N,O) azo ligands

Reactions of 1-{[2-(arylazo)phenyl]iminomethyl}-2-phenol, HL_sal, 1, [where H represents the dissociable protons upon complexation and aryl groups of HL_sal are phenyl for HL¹_sal, p-methylphenyl for HL²_sal, and p-chlorophenyl for HL³_sal], ligands with Ru(H)(CO)(Cl)(PPh₃)₃ afforded complexes of composition [(L_sal)Ru(CO)(Cl)(PPh₃)] and (L_sal)₂Ru where the N,N,O donor tridentate (L_sal)⁻ ligands coordinated the metal centre facially and meridionally, respectively. Stepwise formation of [(L_sal)₂Ru] has been ascertained. Reaction of 1-{[2-(arylazo)phenyl]iminomethyl}-2-napthol, HL_nap, 2, [where H represents the dissociable protons upon complexation and aryl groups of HL_nap are phenyl for HL¹_nap, p-methylphenyl for HL²_nap, and p-chlorophenyl for HL³_nap], ligands with Ru(H)(CO)(Cl)(PPh₃)₃ afforded exclusively the complexes of composition [(L_nap)Ru(CO)(Cl)(PPh₃)], where N,N,O donor tridentate (L_nap)⁻ was facially coordinated. The ligand 1-{[2-(phenylazo)phenyl]aminomethyl}-2-phenol, HL, 3, was prepared by reducing the aldimine function of HL¹_sal. Reaction of HL with Ru(PPh₃)₃Cl₂ afforded new azosalen complex of Ru(III) in concert with regiospecific oxygenation of phenyl ring of HL. All the new ligands were characterized by analytical and spectroscopic techniques. The complexes were characterized by analytical and spectroscopic techniques and subsequently confirmed by the determination of X-ray structures of selected complexes.     

Oligophosphine ligands. XIII. Halo and hydro complexes of ruthenium(II) containing the novel tripod tetrakis(tertiary) phosphine P(CH2CH2CH2PMe2)3

The reaction of the ruthenium complexes RuCl₂(PPh₃)₃, RuCl₂(PPh₃)₄, RuCl₂(PMe₃)₄, RuCl₂(Me₂SO)₄, or RuBr₂(PPh₃)₃ with the tripod tetrakis(tertiary) phosphine P(CH₂CH₂CH₂PMe₂)₃ gave the compounds cis-RuCl₂ [P(CH₂CH₂CH₂PMe₂)₃] (1) and cis-RuBr₂[P(CH₂CH₂CH₂PMe₂)₃] (2). The coordination geometry of 1 and 2 was derived from the ABX₂ type ³¹P NMR patterns of the complexes, as well as from an X-ray structure determination for the chloride 1. Crystals of 1 were found to be monoclinic, space group P2₁/n (Z = 4), with a = 942.0(3), b = 1446.2(4), c = 1680(1) pm, and β = 104.99(4)°. Anisotropic refinement of the structure converged at R = 0.040 and R_w = 0.034 (3318 data). Selected bond lengths are (in pm): RuP(CH₂−)Me₂ (trans-atom P), 235.8(1) and 239.3(1); RuP(CH₂−)Me₂ (trans-atom Cl), 227.9(1); RuP(CH₂−)₃, 225.3(1); RuCl (trans-group P(CH₂−)₃), 252.1(1); and RuCl (trans-group P(CH₂)Me₂), 250.5(1). Reaction of 1 with LiAlH₄ yielded the hydro derivatives cis-Ru(H)Cl[P(CH₂CH₂CH₂PMe₂)₃] (3) and cis-RuH₂[P(CH₂CH₂CH₂PMe₂)₃] (4), which were characterized by IR and ¹H and ³¹p NMR spectroscopy.     

Synthesis, structure and properties of di- and mononuclear ruthenium(III) complexes with N-(benzoyl)-N′-(salicylidene)hydrazine and its derivatives

The reactions of [Ru(PPh₃)₃Cl₂], N-(benzoyl)-N′-(5-R-salicylidene)hydrazines (H₂bhsR, R = H, OCH₃, Cl, Br and NO₂) and triethylamine (1:1:2 mole ratio) in methanol afford mononuclear ruthenium(III) complexes having the general formula trans-[Ru(bhsR)(PPh₃)₂Cl]. In the case of R = H, a dinuclear ruthenium(III) complex of formula [Ru₂(μ-OCH₃)₂(bhsH)₂(PPh₃)₂] has been isolated as a minor product. The complexes are characterized by elemental analysis, magnetic, spectroscopic and electrochemical measurements. The crystal structures of the dinuclear complex and two mononuclear complexes have been determined. In the dinuclear complex, each metal centre is in distorted octahedral NO₄P coordination sphere constituted by the two bridging methoxide groups, one PPh₃ molecule and the meridionally spanning phenolate-O, imine-N and amide-O donor bhsH²⁻. The terminal PPh₃ ligands are trans to each other. In the mononuclear complexes, bhsR²⁻ and the chlorine atom form an NO₂Cl square-plane around the metal centre and the P-atoms of the two PPh₃ molecules occupy the remaining two axial sites to complete a distorted octahedral NO₂ClP₂ coordination sphere. All the complexes display ligand-to-metal charge transfer bands in the visible region of the electronic spectra. The cryomagnetic measurements reveal the antiferromagnetic character of the diruthenium(III) complex. The low-spin mononuclear ruthenium(III) complexes as well as the diruthenium(III) complex display rhombic EPR spectra in frozen solutions. All the complexes are redox active in CH₂Cl₂ solutions. Two successive metal centred oxidations at 0.69 and 1.20 V (versus Ag/AgCl) are observed for the dinuclear complex. The mononuclear complexes display a metal centred reduction in the potential range −0.53 to −0.27 V. The trend in these potential values reflects the polar effect of the substituents on the salicylidene moiety of the tridentate ligand.     

Coordination chemistry of higher oxidation states. Part 15. Cobalt(III) complexes of bi- and multi-dentate phenylphosphines

Six-coordinate cobalt(III) complex trans-[Co{o-C₆H₄(PPh₂)₂}₂X₂]ClO₄, fac-[Co{PhP(CH₂CH₂PPh₂)₂}X₃],cis-[Co{P(CH₂CH₂PPh₂)₃}X₂]ClO₄ and cis-β-[Co{-CH₂P(Ph)CH₂CH₂PPh₂}₂X₂]PF₆ (X = Cl, Br) have been prepared by halogen oxidation of the Co(II) analogues, and characterised by IR, electronic and ³¹P NMR spectroscopy. The failure to obtain complexes with X = I, and with some related ligands is discussed, and the rather low stability of the above complexes is rationalised in terms of steric crowding at the metal centre.